Adaptation and learning of molecular networks as a description of cancer development at the systems-level: Potential use in anti-cancer therapies
arXiv:1306.3371 · doi:10.1016/j.semcancer.2013.06.005
Abstract
There is a widening recognition that cancer cells are products of complex developmental processes. Carcinogenesis and metastasis formation are increasingly described as systems-level, network phenomena. Here we propose that malignant transformation is a two-phase process, where an initial increase of system plasticity is followed by a decrease of plasticity at late stages of carcinogenesis as a model of cellular learning. We describe the hallmarks of increased system plasticity of early, tumor initiating cells, such as increased noise, entropy, conformational and phenotypic plasticity, physical deformability, cell heterogeneity and network rearrangements. Finally, we argue that the large structural changes of molecular networks during cancer development necessitate a rather different targeting strategy in early and late phase of carcinogenesis. Plastic networks of early phase cancer development need a central hit, while rigid networks of late stage primary tumors or established metastases should be attacked by the network influence strategy, such as by edgetic, multi-target, or allo-network drugs. Cancer stem cells need special diagnosis and targeting, since their dormant and rapidly proliferating forms may have more rigid, or more plastic networks, respectively. The extremely high ability to change their rigidity/plasticity may be a key differentiating hallmark of cancer stem cells. The application of early stage-optimized anti-cancer drugs to late-stage patients may be a reason of many failures in anti-cancer therapies. Our hypotheses presented here underlie the need for patient-specific multi-target therapies applying the correct ratio of central hits and network influences -- in an optimized sequence.
arXiv comment8 pages,2 figures, 1 table, 98 references
References in corpus (12)
- Emergence of scaling in random networks
- Evolution of networks
- Temporal Networks
- Structure and dynamics of molecular networks: A novel paradigm of drug discovery. A comprehensive review
- The efficiency of multi-target drugs: the network approach might help drug design
- On dynamic network entropy in cancer
- Allo-network drugs: harnessing allostery in cellular networks
- Creative elements: network-based predictions of active centres in proteins, cellular and social networks
- Uniformly curated signaling pathways reveal tissue-specific cross-talks and support drug target discovery
- Heat shock partially dissociates the overlapping modules of the yeast protein-protein interaction network: a systems level model of adaptation
- Rigidity and flexibility of biological networks
- System level mechanisms of adaptation, learning, memory formation and evolvability: the role of chaperone and other networks